Pharma Sector Weight in Sensex to Hit an 8-year Low: Motilal Oswal
The weightage of healthcare in the S&P BSE Sensex will be at an eight-year low with the exclusion of Dr. Reddy’s Laboratories, said Motilal Oswal Securities in a report. The S&P BSE Sensex has been reshuffled with Vedanta will be replacing Dr. Reddy’s Labs.
The drop in weightage is also due to the significant under-performance of the sector over the last two years. Sun Pharma (weight: 1.7%) will be the only healthcare stock in the benchmark index.
Over the years, the sectoral representation in the Sensex has undergone a sea change in consonance with the changes in the underlying economy – new sectors have evolved, while some of the erstwhile dominant sectors have lost relative importance in the new India, said the report.
Looking for chemical products? Let suppliers reach out to you!
2026-06-17
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Pharma Quality Excellence Awards 2026 - Celebration and Conclusion
-
Pharma Quality Reimagined: Highlights from the 6th Annual Pharma GMP & Quality Management 2026
-
From Feedmill to Food System: VIV Europe 2026 Addresses the Industry's Most Critical Challenges
-
Beyond Compliance: Building Quality Maturity
-
Is the class solidified? From Biotech to Pharma
-
The IPO of the Largest Domestic Metronidazole API Manufacturer has Passed the Meeting
-
Progesterone Market Potential is Huge
-
PharmaReg AfriSummit
-
2022 PHARMA X FOOD X FINE CHEMICAL RAW MATERIALS MATCH MEETING Successfully Held!
-
KOREA PHARM & BIO 2021
Recommend Reading
-
NATO Fund Invests $35 Million in Biotech Startup to Counter Biological Threats
-
Biological E Partners with Recbio to Bring HPV9 Vaccine to India and Global Markets
-
Lupin Secures Tentative U.S. Approval for Its Multiple Sclerosis Tablet
-
Novo Nordisk Faces $46 Billion Windfall Threatened by Wegovy Missteps and Eli Lilly’s Rise
-
Moderna to Cut 10 Percent of Staff as COVID Vaccine Sales Plunge Stock Drops 4 Percent
-
China's Phenol Market in July Exhibited Fluctuations, Market May Continue in August
-
Ammonium Sulfate Market Trend Weakens and Declines (10.23-10.29)
-
ECHEMI High Quality Inquiries (28 Jul- 1 Aug)
-
Phosphate prices slightly increase in China (12.5-12.11)
-
Methanol Market Price Fluctuations and Operations